Psychable's Co-Founder and Chief Strategy Officer, Matt Zemon, shares details about the company's new "Buy One, Give One" ketamine-assisted therapy program.
Similar Posts
Interview With Dustin Robinson
Mr. Psychedelic Law’s Co-Founding Partner, Dustin Robinson, talks about how he became involved with the medicinal psychedelic space.
Cybin Acquires Entheon’s DMT Trial, Numi’s Novamind Acq. Complete, Bad News for MindMed and More
This week in psychedelic business news: Cybin acquires a Phase…
Top 11 Celebrities Whose Lives Were Changed by Psychedelics | Mike Tyson, Seth Rogen, Sting & More
Follow us on Twitter: @PsycSpotlight @Psy_Invest @psy_holy Follow us on…
Interview With Stephen Murphy
Stephen Murphy, Co-Founder of Prohibition Partners, chats about the upcoming PSYCH Investor Summit taking place on April 21, 2021.
Numinus Wellness CEO Discusses MAPS Partnership & How Psychedelics Will Change Society
In this episode James, from The Psychedelic Investor, sits down…
The Spotlight Round Up Video, March 31st
As we continue to strive to be the leading source for news and unique perspective within the emerging sector of medicinal psychedelics, we are excited to debut the Spotlight Roundup! This video series, produced in collaboration with Elk’s Pride Pictures, provides a concise and informative roundup related to some of the most important news developments happening within this rapidly expanding industry. From the latest IPO’s, to new clinical trials, the Spotlight Roundup covers everything you need to know!